Trial · NCT04116112
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Final Infarct Volume | Higher Systolic Blood Pressure (SBP) Target | 46.4 | 95% Confidence Interval 24.5 to 68.2 | Cubic Centimeters | |
| Final Infarct Volume | Lower SBP (<160 mmHg) Target | 50.7 | 95% Confidence Interval 33.7 to 67.7 | Cubic Centimeters | |
| Final Infarct Volume | Lower SBP (<140mmHg) Target | 32.4 | 95% Confidence Interval 18.0 to 46.7 | Cubic Centimeters | |
| Utility-weighted Modified Rankin Score | Higher Systolic Blood Pressure (SBP) Target | 0.58 | 95% Confidence Interval 0.46 to 0.71 | units on a scale (Range 0-1; 1=best) | |
| Utility-weighted Modified Rankin Score | Lower SBP (<160 mmHg) Target | 0.47 | 95% Confidence Interval 0.35 to 0.6 | units on a scale (Range 0-1; 1=best) | |
| Utility-weighted Modified Rankin Score | Lower SBP (<140mmHg) Target | 0.51 | 95% Confidence Interval 0.38 to 0.63 | units on a scale (Range 0-1; 1=best) | |
| Number of Participants With Any Hemorrhagic Transformation | Higher Systolic Blood Pressure (SBP) Target | 12 | Participants | ||
| Number of Participants With Any Hemorrhagic Transformation | Lower SBP (<160 mmHg) Target | 12 | Participants | ||
| Number of Participants With Any Hemorrhagic Transformation | Lower SBP (<140mmHg) Target | 14 | Participants | ||
| Number of Participants With Symptomatic Hemorrhagic Transformation | Higher Systolic Blood Pressure (SBP) Target | 2 | Participants | ||
| Number of Participants With Symptomatic Hemorrhagic Transformation | Lower SBP (<160 mmHg) Target | 1 | Participants | ||
| Number of Participants With Symptomatic Hemorrhagic Transformation | Lower SBP (<140mmHg) Target | 2 | Participants | ||
| Number of Participants With Neurological Worsening Associated With Antihypertensive Treatment | Higher Systolic Blood Pressure (SBP) Target | 0 | Participants | ||
| Number of Participants With Neurological Worsening Associated With Antihypertensive Treatment | Lower SBP (<160 mmHg) Target | 0 | Participants | ||
| Number of Participants With Neurological Worsening Associated With Antihypertensive Treatment | Lower SBP (<140mmHg) Target | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04116112/results